» Articles » PMID: 28975368

Obesogenic Endocrine Disruptors and Obesity: Myths and Truths

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 2017 Oct 5
PMID 28975368
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Obesogenic endocrine disruptors, also known as obesogens, are chemicals potentially involved in weight gain by altering lipid homeostasis and promoting adipogenesis and lipid accumulation. They included compounds to which human population is exposed over daily life such as pesticides/herbicides, industrial and household products, plastics, detergents and personal care products. The window of life during which the exposure happens could lead to different effects. A critical window is during utero and/or neonatal period in which the obesogens could cause subtle changes in gene expression and tissue organization or blunt other levels of biological organization leading to increased susceptibility to diseases in the adulthood. Some of the reasons for this increased sensitivity include the lack of the protective mechanisms that are available in adult such as DNA repair mechanisms, a competent immune system, detoxifying enzymes, liver metabolism and the blood/brain barrier still not fully functional in the fetus or newborn. The mechanisms of action of obesogens lay on their ability to increase the number and/or the size of the adipocytes and to alter appetite, satiety and food preferences. The ability of obesogens to increase fat deposition results in an increased capacity for their own retention due to their lipophilic properties; thus prolonging the exposure and increasing the detrimental metabolic consequences.

Citing Articles

The ENDOMIX perspective: how everyday chemical mixtures impact human health and reproduction by targeting the immune system†.

Gomez-Olarte S, Mailander V, Castro-Neves J, Stojanovska V, Schumacher A, Meyer N Biol Reprod. 2024; 111(6):1170-1187.

PMID: 39446589 PMC: 11647104. DOI: 10.1093/biolre/ioae142.


Association between phthalates exposure and non-alcoholic fatty liver disease under different diagnostic criteria: a cross-sectional study based on NHANES 2017 to 2018.

Zou J, Gu Q, Gu D Front Public Health. 2024; 12:1407976.

PMID: 39386944 PMC: 11462993. DOI: 10.3389/fpubh.2024.1407976.


[Synthetic phenolic compounds perturb lipid metabolism and induce obesogenic effects].

Liu H, Sun Z, Liu Q, Zhou Q, Jiang G Se Pu. 2024; 42(2):131-141.

PMID: 38374593 PMC: 10877482. DOI: 10.3724/SP.J.1123.2023.12018.


Increasing Access to Medical Care for Hispanic Women Without Insurance: A Mobile Clinic Approach.

Phelan S, Tseng M, Kelleher A, Kim E, Macedo C, Charbonneau V J Immigr Minor Health. 2024; 26(3):482-491.

PMID: 38170427 DOI: 10.1007/s10903-023-01575-1.


Does bisphenol A (BPA) participates in the pathogenesis of Polycystic Ovary Syndrome (PCOS)?.

Urbanetz L, Soares Junior J, Maciel G, Simoes R, Baracat M, Baracat E Clinics (Sao Paulo). 2023; 78:100310.

PMID: 38008036 PMC: 10757276. DOI: 10.1016/j.clinsp.2023.100310.